dysmenorrhea. primary dysmenorrhea
Conditions
Interventions
Intervention 1: intervention: 50 mg capsul of zinc sulfate, QD, for 3 month. Intervention 2: control: placebo same method as the intervention group. QD 1 cap for 3 month.
Treatment - Drugs
intervention: 50 mg capsul of zinc sulfate, QD, for 3 month
control: placebo same method as the intervention group. QD 1 cap for 3 month
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
14 Years to 18 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: history of regular menstrual cycles of 21-35 days with actual menstruation period of 3 to 7 days; if the participants experienced at least 4 consecutive painful menstruation periods in the past six months; the pain started one day before or at the starting day of menstruation and if dysmenorrhea disturbed daily activity of the patients for at least one day per month. After describing the study protocol, an informed consent was taken from the parents of patients. Enrolled patients underwent pelvic ultrasonography examination by a gynecologist. The patients were excluded if she had a clinically significant medical history or active disease; if a pelvic pathology was diagnosed by the gynecologist; if she used other medications or supplements and if she was not interested in using the drug and filling the pain charts of the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain duration. Timepoint: in 3 menstruation cyclein 3 month. Method of measurement: chart the day she has pain.;Pain severity. Timepoint: in 3 menstruation cyclein 3 month. Method of measurement: pain rating scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAida Amanat
Jahrom University of Medical Sciences
Outcome results
None listed